BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24668054)

  • 1. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
    Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
    Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
    Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
    Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
    Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
    Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
    Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
    Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esthesioneuroblastoma: a meta-analysis and review.
    Dulguerov P; Allal AS; Calcaterra TC
    Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
    Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
    Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
    Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
    Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
    Vuong HG; Ngo TNM; Dunn IF
    J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
    Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
    McElroy EA; Buckner JC; Lewis JE
    Neurosurgery; 1998 May; 42(5):1023-7; discussion 1027-8. PubMed ID: 9588546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure and outcome in esthesioneuroblastoma.
    Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
    de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
    Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.
    Jethanamest D; Morris LG; Sikora AG; Kutler DI
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):276-80. PubMed ID: 17372086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.
    Goshtasbi K; Abiri A; Abouzari M; Sahyouni R; Wang BY; Tajudeen BA; Hsu FPK; Cadena G; Kuan EC
    Int Forum Allergy Rhinol; 2019 Sep; 9(9):1054-1062. PubMed ID: 31251848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 20 adults esthesioneuroblastoma with combined therapy].
    Li JS; Xie FY; Peng M; Han F
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):36-9. PubMed ID: 19484986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.